Claw

Implanet granted regulatory clearance in the USA (510k) and Europe (CE) for the Jazz Claw

Bordeaux, Boston, May 23, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in…